Key facts
- SynPhNe’s last known valuation is $37.2M (Mar 2024).
- It has raised $16.0M; the latest was Later Stage VC in Apr 2025.
- Notable investors include UCEA Capital Partners, Event Horizon Capital, Isay Yutkevich, NTUitive, Ravinder Kichloo.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for SynPhNe
- ·The full record, as it builds
Funding rounds
No funding rounds for SynPhNe are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SynPhNe
Developer of a wearable connected health system designed to help people train their brain and body. The company's system consists of an arm and headgear that senses muscle and brain signals that communicate wirelessly with computer software that trains the user in how to manage conscious and unconscious responses and leverage the ability of the brain to rewire itself, enabling the healthcare industry to treat strokes, cerebral palsy, traumatic brain injury, dyslexia, early dementia, and stress disorders.
- Sector
- Healthcare
- HQ
- Somerville, NJ, United States
- Founded
- 2013
- Employees
- 18
- Website
- synphne.com/
- Ownership
- Privately Held (backing)
SynPhNe doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SynPhNe shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SynPhNe in its N-PORT filings yet. We sweep new filings monthly.